Kim K - Search Results

1

Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer.

Ban EJ, Kim D, Kim JK, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY, Kim K. Ban EJ, et al. Among authors: kim jk, kim d, kim k. Endocrinol Metab (Seoul). 2021 Feb;36(1):96-105. doi: 10.3803/EnM.2020.819. Epub 2021 Feb 24. Endocrinol Metab (Seoul). 2021. PMID: 33677931 Free PMC article.

2

Protein kinase CK2 modulation of pyruvate kinase M isoforms augments the Warburg effect in cancer cells.

Yang KM, Kim K. Yang KM, et al. Among authors: kim k. J Cell Biochem. 2018 Nov;119(10):8501-8510. doi: 10.1002/jcb.27078. Epub 2018 Jul 17. J Cell Biochem. 2018. PMID: 30015359

3

The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.

Kim HJ, Eoh KJ, Kim LK, Nam EJ, Yoon SO, Kim KH, Lee JK, Kim SW, Kim YT. Kim HJ, et al. Oncotarget. 2016 Dec 13;7(50):83001-83016. doi: 10.18632/oncotarget.12863. Oncotarget. 2016. PMID: 27792998 Free PMC article.

4

The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.

Choi KC, Oh SY, Kang HB, Lee YH, Haam S, Kim HI, Kim K, Ahn YH, Kim KS, Yoon HG. Choi KC, et al. Among authors: kim hi, kim ks, kim k. Biochem J. 2008 Apr 1;411(1):19-26. doi: 10.1042/BJ20071393. Biochem J. 2008. PMID: 18052923

5

The combination of TRAIL treatment and cancer cell selective expression of TRAIL-death receptor DR4 induces cell death in TRAIL-resistant cancer cells.

Choi E, Kim Y, Kim K. Choi E, et al. Among authors: kim y, kim k. Yonsei Med J. 2006 Feb 28;47(1):55-62. doi: 10.3349/ymj.2006.47.1.55. Yonsei Med J. 2006. PMID: 16502485 Free PMC article.

6

Protein kinase casein kinase 2-mediated upregulation of N-cadherin confers anoikis resistance on esophageal carcinoma cells.

Ko H, Kim S, Jin CH, Lee E, Ham S, Yook JI, Kim K. Ko H, et al. Among authors: kim s, kim k. Mol Cancer Res. 2012 Aug;10(8):1032-8. doi: 10.1158/1541-7786.MCR-12-0261. Epub 2012 Jul 5. Mol Cancer Res. 2012. PMID: 22767590

7

p53 and microRNA-34 are suppressors of canonical Wnt signaling.

Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li XY, Kang SE, Cha SY, Ryu JK, Na JM, Park C, Kim K, Lee S, Gumbiner BM, Yook JI, Weiss SJ. Kim NH, et al. Among authors: kim ng, kim hs, kim k. Sci Signal. 2011 Nov 1;4(197):ra71. doi: 10.1126/scisignal.2001744. Sci Signal. 2011. PMID: 22045851 Free PMC article.

8

Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and -independent pathways.

Kim JS, Lee JM, Chwae YJ, Kim YH, Lee JH, Kim K, Lee TH, Kim SJ, Park JH. Kim JS, et al. Among authors: kim yh, kim sj, kim k. Biochem Pharmacol. 2004 Apr 15;67(8):1459-68. doi: 10.1016/j.bcp.2003.12.013. Biochem Pharmacol. 2004. PMID: 15041463

9

Silencing Bcl-X(L) in cancer therapy.

Kim K. Kim K. Cancer Biol Ther. 2005 Apr;4(4):398-9. doi: 10.4161/cbt.4.4.1761. Epub 2005 Apr 27. Cancer Biol Ther. 2005. PMID: 15908790 No abstract available.

10

Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.

Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H. Kim YJ, et al. Among authors: kim tj, kim k. Toxicology. 2014 Aug 1;322:23-33. doi: 10.1016/j.tox.2014.04.002. Epub 2014 May 2. Toxicology. 2014. PMID: 24793912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51,726 results

Search Page